CG
Carmignac Gestion’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $159M | Buy |
391,279
+202,107
| +107% | +$82M | 2.44% | 12 |
|
2025
Q1 | $94.2M | Buy |
189,172
+33,019
| +21% | +$16.4M | 1.55% | 21 |
|
2024
Q4 | $81.2M | Buy |
156,153
+100,891
| +183% | +$52.5M | 1.29% | 25 |
|
2024
Q3 | $34.2M | Sell |
55,262
-26,491
| -32% | -$16.4M | 0.57% | 36 |
|
2024
Q2 | $45.2M | Buy |
81,753
+14,067
| +21% | +$7.78M | 0.78% | 32 |
|
2024
Q1 | $39.3M | Sell |
67,686
-6,472
| -9% | -$3.76M | 0.62% | 33 |
|
2023
Q4 | $39.4M | Sell |
74,158
-156,342
| -68% | -$83M | 0.66% | 34 |
|
2023
Q3 | $117M | Buy |
230,500
+167,296
| +265% | +$84.7M | 2.14% | 16 |
|
2023
Q2 | $32.9M | Buy |
63,204
+26,692
| +73% | +$13.9M | 0.57% | 40 |
|
2023
Q1 | $21M | Buy |
36,512
+2,488
| +7% | +$1.43M | 0.35% | 48 |
|
2022
Q4 | $18.8M | Buy |
34,024
+284
| +0.8% | +$157K | 0.34% | 49 |
|
2022
Q3 | $17.2M | Sell |
33,740
-1,444
| -4% | -$735K | 0.37% | 44 |
|
2022
Q2 | $19.1M | Sell |
35,184
-4,224
| -11% | -$2.29M | 0.4% | 40 |
|
2022
Q1 | $23.3M | Buy |
39,408
+957
| +2% | +$566K | 0.38% | 42 |
|
2021
Q4 | $25.6M | Buy |
38,451
+8,651
| +29% | +$5.77M | 0.36% | 42 |
|
2021
Q3 | $17.1M | Buy |
29,800
+2,170
| +8% | +$1.24M | 0.21% | 56 |
|
2021
Q2 | $13.9M | Buy |
27,630
+1,201
| +5% | +$606K | 0.16% | 60 |
|
2021
Q1 | $12M | Buy |
26,429
+1,844
| +8% | +$841K | 0.14% | 61 |
|
2020
Q4 | $11.4M | Sell |
24,585
-277
| -1% | -$129K | 0.12% | 66 |
|
2020
Q3 | $11M | Sell |
24,862
-627
| -2% | -$277K | 0.13% | 61 |
|
2020
Q2 | $9.23M | Sell |
25,489
-253,121
| -91% | -$91.6M | 0.13% | 58 |
|
2020
Q1 | $79M | Sell |
278,610
-255,841
| -48% | -$72.6M | 1.35% | 29 |
|
2019
Q4 | $174M | Buy |
534,451
+117,962
| +28% | +$38.3M | 2.32% | 15 |
|
2019
Q3 | $121M | Buy |
416,489
+415,443
| +39,717% | +$121M | 1.53% | 25 |
|
2019
Q2 | $307K | Buy |
+1,046
| New | +$307K | ﹤0.01% | 99 |
|
2016
Q4 | – | Sell |
-4,065,036
| Closed | -$647M | – | 88 |
|
2016
Q3 | $647M | Buy |
4,065,036
+18,486
| +0.5% | +$2.94M | 4.83% | 6 |
|
2016
Q2 | $598M | Buy |
4,046,550
+763,421
| +23% | +$113M | 5.12% | 7 |
|
2016
Q1 | $465M | Buy |
3,283,129
+13,600
| +0.4% | +$1.93M | 4.53% | 8 |
|
2015
Q4 | $464M | Buy |
3,269,529
+714
| +0% | +$101K | 5.11% | 8 |
|
2015
Q3 | $400M | Sell |
3,268,815
-12,300
| -0.4% | -$1.5M | 5.07% | 9 |
|
2015
Q2 | $426M | Buy |
3,281,115
+11,300
| +0.3% | +$1.47M | 3.8% | 11 |
|
2015
Q1 | $439M | Buy |
3,269,815
+10,286
| +0.3% | +$1.38M | 3.89% | 11 |
|
2014
Q4 | $408M | Buy |
3,259,529
+5,500
| +0.2% | +$689K | 3.73% | 13 |
|
2014
Q3 | $396M | Buy |
3,254,029
+2,900
| +0.1% | +$353K | 3.39% | 13 |
|
2014
Q2 | $384M | Buy |
3,251,129
+330,068
| +11% | +$38.9M | 3% | 17 |
|
2014
Q1 | $351M | Buy |
2,921,061
+1,530,497
| +110% | +$184M | 2.57% | 22 |
|
2013
Q4 | $155M | Buy |
+1,390,564
| New | +$155M | 1.15% | 24 |
|